Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

Overview of attention for article published in BMC Cancer, February 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

So far, Altmetric has seen 10 X posts from 10 X users, with an upper bound of 17,954 followers.

RT @dr_yakupergun: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression u…

RT @dr_yakupergun: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression u…

RT @dr_yakupergun: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression u…

RT @dr_yakupergun: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression u…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.